Global Nuclear Medicine & Radiopharmaceuticals Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 94

Published Date: 18 Mar 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.

According to our (Global Info Research) latest study, the global Nuclear Medicine & Radiopharmaceuticals market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The major players in Chian Nuclear Medicine & Radiopharmaceuticals market include China Isotope & Radiation, Shanghai Atom Kexing, Advanced Molecular-imaging Solution, etc. Beijing and Chengdu are main markets, they occupy about 65% of the whole market. Diagnostic is the main type, with a share about 80%. Cardiology is the main application, which holds a share about 40%.

This report is a detailed and comprehensive analysis for global Nuclear Medicine & Radiopharmaceuticals market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Nuclear Medicine & Radiopharmaceuticals market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Nuclear Medicine & Radiopharmaceuticals market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Nuclear Medicine & Radiopharmaceuticals market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Nuclear Medicine & Radiopharmaceuticals market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Nuclear Medicine & Radiopharmaceuticals
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Nuclear Medicine & Radiopharmaceuticals market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include China Isotope & Radiation, Dongcheng, Jaco, Ciaeriar and Advanced Molecular-imaging Solution and  etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Nuclear Medicine & Radiopharmaceuticals market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Diagnostic
    Therapeutic

Market segment by Application
    Oncology
    Thyroid
    Cardiology
    Others

Major players covered
    China Isotope & Radiation
    Dongcheng
    Jaco
    Ciaeriar
    Advanced Molecular-imaging Solution
    Shanghai Atom Kexing

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nuclear Medicine & Radiopharmaceuticals product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Nuclear Medicine & Radiopharmaceuticals, with price, sales, revenue and global market share of Nuclear Medicine & Radiopharmaceuticals from 2018 to 2023.
Chapter 3, the Nuclear Medicine & Radiopharmaceuticals competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nuclear Medicine & Radiopharmaceuticals breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Nuclear Medicine & Radiopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Nuclear Medicine & Radiopharmaceuticals.
Chapter 14 and 15, to describe Nuclear Medicine & Radiopharmaceuticals sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Nuclear Medicine & Radiopharmaceuticals
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Diagnostic
        1.3.3 Therapeutic
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Oncology
        1.4.3 Thyroid
        1.4.4 Cardiology
        1.4.5 Others
    1.5 Global Nuclear Medicine & Radiopharmaceuticals Market Size & Forecast
        1.5.1 Global Nuclear Medicine & Radiopharmaceuticals Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity (2018-2029)
        1.5.3 Global Nuclear Medicine & Radiopharmaceuticals Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 China Isotope & Radiation
        2.1.1 China Isotope & Radiation Details
        2.1.2 China Isotope & Radiation Major Business
        2.1.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product and Services
        2.1.4 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 China Isotope & Radiation Recent Developments/Updates
    2.2 Dongcheng
        2.2.1 Dongcheng Details
        2.2.2 Dongcheng Major Business
        2.2.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Product and Services
        2.2.4 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Dongcheng Recent Developments/Updates
    2.3 Jaco
        2.3.1 Jaco Details
        2.3.2 Jaco Major Business
        2.3.3 Jaco Nuclear Medicine & Radiopharmaceuticals Product and Services
        2.3.4 Jaco Nuclear Medicine & Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Jaco Recent Developments/Updates
    2.4 Ciaeriar
        2.4.1 Ciaeriar Details
        2.4.2 Ciaeriar Major Business
        2.4.3 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product and Services
        2.4.4 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Ciaeriar Recent Developments/Updates
    2.5 Advanced Molecular-imaging Solution
        2.5.1 Advanced Molecular-imaging Solution Details
        2.5.2 Advanced Molecular-imaging Solution Major Business
        2.5.3 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product and Services
        2.5.4 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Advanced Molecular-imaging Solution Recent Developments/Updates
    2.6 Shanghai Atom Kexing
        2.6.1 Shanghai Atom Kexing Details
        2.6.2 Shanghai Atom Kexing Major Business
        2.6.3 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product and Services
        2.6.4 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Shanghai Atom Kexing Recent Developments/Updates

3 Competitive Environment: Nuclear Medicine & Radiopharmaceuticals by Manufacturer
    3.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Manufacturer (2018-2023)
    3.3 Global Nuclear Medicine & Radiopharmaceuticals Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Nuclear Medicine & Radiopharmaceuticals by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Nuclear Medicine & Radiopharmaceuticals Manufacturer Market Share in 2022
        3.4.2 Top 6 Nuclear Medicine & Radiopharmaceuticals Manufacturer Market Share in 2022
    3.5 Nuclear Medicine & Radiopharmaceuticals Market: Overall Company Footprint Analysis
        3.5.1 Nuclear Medicine & Radiopharmaceuticals Market: Region Footprint
        3.5.2 Nuclear Medicine & Radiopharmaceuticals Market: Company Product Type Footprint
        3.5.3 Nuclear Medicine & Radiopharmaceuticals Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Region
        4.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Region (2018-2029)
        4.1.2 Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Region (2018-2029)
        4.1.3 Global Nuclear Medicine & Radiopharmaceuticals Average Price by Region (2018-2029)
    4.2 North America Nuclear Medicine & Radiopharmaceuticals Consumption Value (2018-2029)
    4.3 Europe Nuclear Medicine & Radiopharmaceuticals Consumption Value (2018-2029)
    4.4 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Consumption Value (2018-2029)
    4.5 South America Nuclear Medicine & Radiopharmaceuticals Consumption Value (2018-2029)
    4.6 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2018-2029)
    5.2 Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Type (2018-2029)
    5.3 Global Nuclear Medicine & Radiopharmaceuticals Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2018-2029)
    6.2 Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Application (2018-2029)
    6.3 Global Nuclear Medicine & Radiopharmaceuticals Average Price by Application (2018-2029)

7 North America
    7.1 North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2018-2029)
    7.2 North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2018-2029)
    7.3 North America Nuclear Medicine & Radiopharmaceuticals Market Size by Country
        7.3.1 North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Country (2018-2029)
        7.3.2 North America Nuclear Medicine & Radiopharmaceuticals Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2018-2029)
    8.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2018-2029)
    8.3 Europe Nuclear Medicine & Radiopharmaceuticals Market Size by Country
        8.3.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Country (2018-2029)
        8.3.2 Europe Nuclear Medicine & Radiopharmaceuticals Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size by Region
        9.3.1 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2018-2029)
    10.2 South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2018-2029)
    10.3 South America Nuclear Medicine & Radiopharmaceuticals Market Size by Country
        10.3.1 South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Country (2018-2029)
        10.3.2 South America Nuclear Medicine & Radiopharmaceuticals Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Market Size by Country
        11.3.1 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Nuclear Medicine & Radiopharmaceuticals Market Drivers
    12.2 Nuclear Medicine & Radiopharmaceuticals Market Restraints
    12.3 Nuclear Medicine & Radiopharmaceuticals Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Nuclear Medicine & Radiopharmaceuticals and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Nuclear Medicine & Radiopharmaceuticals
    13.3 Nuclear Medicine & Radiopharmaceuticals Production Process
    13.4 Nuclear Medicine & Radiopharmaceuticals Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Nuclear Medicine & Radiopharmaceuticals Typical Distributors
    14.3 Nuclear Medicine & Radiopharmaceuticals Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
    Table 4. China Isotope & Radiation Major Business
    Table 5. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product and Services
    Table 6. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. China Isotope & Radiation Recent Developments/Updates
    Table 8. Dongcheng Basic Information, Manufacturing Base and Competitors
    Table 9. Dongcheng Major Business
    Table 10. Dongcheng Nuclear Medicine & Radiopharmaceuticals Product and Services
    Table 11. Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Dongcheng Recent Developments/Updates
    Table 13. Jaco Basic Information, Manufacturing Base and Competitors
    Table 14. Jaco Major Business
    Table 15. Jaco Nuclear Medicine & Radiopharmaceuticals Product and Services
    Table 16. Jaco Nuclear Medicine & Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Jaco Recent Developments/Updates
    Table 18. Ciaeriar Basic Information, Manufacturing Base and Competitors
    Table 19. Ciaeriar Major Business
    Table 20. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product and Services
    Table 21. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Ciaeriar Recent Developments/Updates
    Table 23. Advanced Molecular-imaging Solution Basic Information, Manufacturing Base and Competitors
    Table 24. Advanced Molecular-imaging Solution Major Business
    Table 25. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product and Services
    Table 26. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Advanced Molecular-imaging Solution Recent Developments/Updates
    Table 28. Shanghai Atom Kexing Basic Information, Manufacturing Base and Competitors
    Table 29. Shanghai Atom Kexing Major Business
    Table 30. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product and Services
    Table 31. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Shanghai Atom Kexing Recent Developments/Updates
    Table 33. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 34. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 35. Global Nuclear Medicine & Radiopharmaceuticals Average Price by Manufacturer (2018-2023) & (USD/Unit)
    Table 36. Market Position of Manufacturers in Nuclear Medicine & Radiopharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 37. Head Office and Nuclear Medicine & Radiopharmaceuticals Production Site of Key Manufacturer
    Table 38. Nuclear Medicine & Radiopharmaceuticals Market: Company Product Type Footprint
    Table 39. Nuclear Medicine & Radiopharmaceuticals Market: Company Product Application Footprint
    Table 40. Nuclear Medicine & Radiopharmaceuticals New Market Entrants and Barriers to Market Entry
    Table 41. Nuclear Medicine & Radiopharmaceuticals Mergers, Acquisition, Agreements, and Collaborations
    Table 42. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Region (2018-2023) & (K Units)
    Table 43. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Region (2024-2029) & (K Units)
    Table 44. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Region (2018-2023) & (USD Million)
    Table 45. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Region (2024-2029) & (USD Million)
    Table 46. Global Nuclear Medicine & Radiopharmaceuticals Average Price by Region (2018-2023) & (USD/Unit)
    Table 47. Global Nuclear Medicine & Radiopharmaceuticals Average Price by Region (2024-2029) & (USD/Unit)
    Table 48. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2018-2023) & (K Units)
    Table 49. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2024-2029) & (K Units)
    Table 50. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Type (2018-2023) & (USD Million)
    Table 51. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Type (2024-2029) & (USD Million)
    Table 52. Global Nuclear Medicine & Radiopharmaceuticals Average Price by Type (2018-2023) & (USD/Unit)
    Table 53. Global Nuclear Medicine & Radiopharmaceuticals Average Price by Type (2024-2029) & (USD/Unit)
    Table 54. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2018-2023) & (K Units)
    Table 55. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2024-2029) & (K Units)
    Table 56. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Application (2018-2023) & (USD Million)
    Table 57. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Application (2024-2029) & (USD Million)
    Table 58. Global Nuclear Medicine & Radiopharmaceuticals Average Price by Application (2018-2023) & (USD/Unit)
    Table 59. Global Nuclear Medicine & Radiopharmaceuticals Average Price by Application (2024-2029) & (USD/Unit)
    Table 60. North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2018-2023) & (K Units)
    Table 61. North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2024-2029) & (K Units)
    Table 62. North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2018-2023) & (K Units)
    Table 63. North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2024-2029) & (K Units)
    Table 64. North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Country (2018-2023) & (K Units)
    Table 65. North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Country (2024-2029) & (K Units)
    Table 66. North America Nuclear Medicine & Radiopharmaceuticals Consumption Value by Country (2018-2023) & (USD Million)
    Table 67. North America Nuclear Medicine & Radiopharmaceuticals Consumption Value by Country (2024-2029) & (USD Million)
    Table 68. Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2018-2023) & (K Units)
    Table 69. Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2024-2029) & (K Units)
    Table 70. Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2018-2023) & (K Units)
    Table 71. Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2024-2029) & (K Units)
    Table 72. Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Country (2018-2023) & (K Units)
    Table 73. Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Country (2024-2029) & (K Units)
    Table 74. Europe Nuclear Medicine & Radiopharmaceuticals Consumption Value by Country (2018-2023) & (USD Million)
    Table 75. Europe Nuclear Medicine & Radiopharmaceuticals Consumption Value by Country (2024-2029) & (USD Million)
    Table 76. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2018-2023) & (K Units)
    Table 77. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2024-2029) & (K Units)
    Table 78. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2018-2023) & (K Units)
    Table 79. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2024-2029) & (K Units)
    Table 80. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Region (2018-2023) & (K Units)
    Table 81. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Region (2024-2029) & (K Units)
    Table 82. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Consumption Value by Region (2018-2023) & (USD Million)
    Table 83. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Consumption Value by Region (2024-2029) & (USD Million)
    Table 84. South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2018-2023) & (K Units)
    Table 85. South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2024-2029) & (K Units)
    Table 86. South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2018-2023) & (K Units)
    Table 87. South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2024-2029) & (K Units)
    Table 88. South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Country (2018-2023) & (K Units)
    Table 89. South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Country (2024-2029) & (K Units)
    Table 90. South America Nuclear Medicine & Radiopharmaceuticals Consumption Value by Country (2018-2023) & (USD Million)
    Table 91. South America Nuclear Medicine & Radiopharmaceuticals Consumption Value by Country (2024-2029) & (USD Million)
    Table 92. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2018-2023) & (K Units)
    Table 93. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Type (2024-2029) & (K Units)
    Table 94. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2018-2023) & (K Units)
    Table 95. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Application (2024-2029) & (K Units)
    Table 96. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Region (2018-2023) & (K Units)
    Table 97. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity by Region (2024-2029) & (K Units)
    Table 98. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Consumption Value by Region (2018-2023) & (USD Million)
    Table 99. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Consumption Value by Region (2024-2029) & (USD Million)
    Table 100. Nuclear Medicine & Radiopharmaceuticals Raw Material
    Table 101. Key Manufacturers of Nuclear Medicine & Radiopharmaceuticals Raw Materials
    Table 102. Nuclear Medicine & Radiopharmaceuticals Typical Distributors
    Table 103. Nuclear Medicine & Radiopharmaceuticals Typical Customers
List of Figures
    Figure 1. Nuclear Medicine & Radiopharmaceuticals Picture
    Figure 2. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Type in 2022
    Figure 4. Diagnostic Examples
    Figure 5. Therapeutic Examples
    Figure 6. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 7. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Application in 2022
    Figure 8. Oncology Examples
    Figure 9. Thyroid Examples
    Figure 10. Cardiology Examples
    Figure 11. Others Examples
    Figure 12. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 13. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 14. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity (2018-2029) & (K Units)
    Figure 15. Global Nuclear Medicine & Radiopharmaceuticals Average Price (2018-2029) & (USD/Unit)
    Figure 16. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Manufacturer in 2022
    Figure 17. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Manufacturer in 2022
    Figure 18. Producer Shipments of Nuclear Medicine & Radiopharmaceuticals by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 19. Top 3 Nuclear Medicine & Radiopharmaceuticals Manufacturer (Consumption Value) Market Share in 2022
    Figure 20. Top 6 Nuclear Medicine & Radiopharmaceuticals Manufacturer (Consumption Value) Market Share in 2022
    Figure 21. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Region (2018-2029)
    Figure 22. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Region (2018-2029)
    Figure 23. North America Nuclear Medicine & Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 24. Europe Nuclear Medicine & Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 25. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 26. South America Nuclear Medicine & Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 27. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 28. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Type (2018-2029)
    Figure 29. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Type (2018-2029)
    Figure 30. Global Nuclear Medicine & Radiopharmaceuticals Average Price by Type (2018-2029) & (USD/Unit)
    Figure 31. Global Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Application (2018-2029)
    Figure 32. Global Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Application (2018-2029)
    Figure 33. Global Nuclear Medicine & Radiopharmaceuticals Average Price by Application (2018-2029) & (USD/Unit)
    Figure 34. North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Type (2018-2029)
    Figure 35. North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Application (2018-2029)
    Figure 36. North America Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Country (2018-2029)
    Figure 37. North America Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Country (2018-2029)
    Figure 38. United States Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Canada Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Mexico Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 41. Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Type (2018-2029)
    Figure 42. Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Application (2018-2029)
    Figure 43. Europe Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Country (2018-2029)
    Figure 44. Europe Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Country (2018-2029)
    Figure 45. Germany Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. France Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. United Kingdom Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Russia Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Italy Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 50. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Type (2018-2029)
    Figure 51. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Application (2018-2029)
    Figure 52. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Region (2018-2029)
    Figure 53. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Region (2018-2029)
    Figure 54. China Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Japan Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Korea Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. India Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Southeast Asia Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. Australia Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Type (2018-2029)
    Figure 61. South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Application (2018-2029)
    Figure 62. South America Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Country (2018-2029)
    Figure 63. South America Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Country (2018-2029)
    Figure 64. Brazil Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. Argentina Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 66. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Type (2018-2029)
    Figure 67. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Application (2018-2029)
    Figure 68. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Quantity Market Share by Region (2018-2029)
    Figure 69. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Consumption Value Market Share by Region (2018-2029)
    Figure 70. Turkey Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Egypt Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Saudi Arabia Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. South Africa Nuclear Medicine & Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 74. Nuclear Medicine & Radiopharmaceuticals Market Drivers
    Figure 75. Nuclear Medicine & Radiopharmaceuticals Market Restraints
    Figure 76. Nuclear Medicine & Radiopharmaceuticals Market Trends
    Figure 77. Porters Five Forces Analysis
    Figure 78. Manufacturing Cost Structure Analysis of Nuclear Medicine & Radiopharmaceuticals in 2022
    Figure 79. Manufacturing Process Analysis of Nuclear Medicine & Radiopharmaceuticals
    Figure 80. Nuclear Medicine & Radiopharmaceuticals Industrial Chain
    Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 82. Direct Channel Pros & Cons
    Figure 83. Indirect Channel Pros & Cons
    Figure 84. Methodology
    Figure 85. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Nuclear Medicine & Radiopharmaceuticals Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Nuclear Medicine & Radiopharmaceuticals Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 13 Sep 2024

date Pharma & Healthcare

Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis and, increasingly, for the therapy of diseases.

Global Nuclear Medicine & Radiopharmaceuticals Supply, Demand and Key Producers, 2024-2030

Global Nuclear Medicine & Radiopharmaceuticals Supply, Demand and Key Producers, 2024-2030

date 13 Sep 2024

date Pharma & Healthcare

Product Tags

Nuclear Medicine & Radiopharmaceuticals

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>